The Nutshell

EPO Revokes Broad’s CRISPR Patent
EPO Revokes Broad’s CRISPR Patent

Shortly after ruling out the earliest priority dates on a foundational patent for CRISPR gene-editing technology, the European Patent Office rescinded the patent entirely—and more are likely to follow.